How Can We Help?
You are here:
< Back

Guanoxan is a sympatholytic drug that was marketed as Envacar by Pfizer in the UK to treat high blood pressure. It was not widely used and was eventually withdrawn from the market due to liver toxicity.[1][2]

References

  1. ^ Broadley KJ (1996). Autonomic Pharmacology. CRC Press. p. 276. ISBN 9780748405565.
  2. ^ Wardell WM, Lasagna L (1975). Regulation and drug development. Washington: American Enterprise Institute for Public Policy Research. p. 65. ISBN 9780844731674.



Categories
Table of Contents